DRKS00025005已完成不适用
Prostate-specific Membrane Antigen (PSMA) expression in endometrial cancer
niversitätsklinikum Freiburg Klinik für Frauenheilkunde0 个研究点目标入组 61 人开始时间: 2021年4月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- Female
入选标准
- •Patients with histologically verified invasive endometrial carcinoma are included in this study.
排除标准
- •- no declaration of consent
- •- other oncological disease
- •- intake of selective oestrogen receptor modulators (SERM, for example tamoxifen)
- •- after ovarian stimulation therapy
- •- histologically proved sarcoma, neuroendocrine tumour or mixed tumour
- •- cytostatic or radiotherapy administered before tissue sampling
研究者
相似试验
尚未招募
不适用
Prostate-specific Membrane Antigen (PSMA) expression in cervical carcinomaC53.9Cervix uteri, unspecifiedDRKS00023289niversitätsklinikum FreiburgKlinik für Frauenheilkunde100
尚未招募
不适用
Prostate-specific membrane antigen (PSMA) expression in ovarian carcinomaC56Malignant neoplasm of ovaryDRKS00023240niversitätsklinikum Freiburg Klinik für Frauenheilkunde100
招募中
2 期
Prostate-Specific Membrane Antigen (PSMA) Intensity Can be Altered by Androgen and phospho-SrC Obstructiometastatic castration-resistant prostate cancerCancer - ProstateACTRN12621000611820St Vincent's Hospital, Sydney22
招募中
2 期
Expression of prostate specific membrane antigen (PSMA) in soft tissue sarcomas and urothelial cell carcinomas: implications for tumour-specific molecular imaging and treatment?cohort 1: soft tissue cancercohort 2: transitional cell carcinomasoft tissue tumour1002838910004994bladder cancerNL-OMON54064eids Universitair Medisch Centrum120
尚未招募
1 期
Emerging digital imaging-guided theranostic therapy for newly diagnosed high risk prostate cancer patients: A feasibility studyCancer - ProstateProstate CancerACTRN12620001358932I-MED Radiology Network5